Israel’s next tech revolution is no mystery. It is a roadmap with three bold routes and a single destination: a nation that ...
ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip ...
Clinical Trials Arena on MSN
FDA’s latest CGT guidance streamlines path for in vivo CAR-T development
The FDA has released three new guidance documents on cell and gene therapy development, covering clinical trial design and post-market studies.
Three Qatari officials have been killed in a car crash near the Egyptian Red Sea resort of Sharm el-Sheikh, according to the Qatari Embassy in Cairo. In a statement on Sunday, the diplomatic mission ...
When Martin Truex Jr. hung up his firesuit in 2024, Joe Gibbs was not worried. The stellar Cup Series team owner roped in a worthy driver to fill in Truex’s No. 19 Toyota seat. And within a year, that ...
A government official in Ecuador has accused protesters of attempting to attack President Daniel Noboa, alleging that a group of approximately 500 people surrounded his vehicle and threw rocks. The ...
ViroCell Biologics and AvenCell Therapeutics Announce Retroviral Vector Manufacturing Collaboration to Accelerate Development of Novel Allogeneic CAR-T Therapies for Blood Cancers AvenCell selected ...
As the weather warms and summer nears, police leaders claim they're prepared to tackle one of Philadelphia's long-standing quality of life problems: illegal car meetups and ATVs on city streets. The ...
Stoffels projected pivotal development for GLPG5101 in 2026, with anticipated approval in 2028. The company plans to expand its cell therapy pipeline in 2026, including at least one additional ...
With a zero-to-60 mph time of around 4.0 seconds and a 12-second quarter-mile time, it outpaces any Ferrari Testarossa, Lamborghini Countach, or Jaguar XJ220 of the day. Only 17 examples of the Vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results